Study of Medication and Placebo Response in Major Depression
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of the research study is to use recordings of brain electrical activity
(through electroencephalogram, or EEG) and symptom measurements to determine whether patients
are likely to show a response to medication or placebo treatment during a treatment trial for
depression.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
Eli Lilly and Company Massachusetts General Hospital Pfizer